R. O'Hara

发表

Completion of the sequence analysis and comparisons of genome segment 2 (encoding outer capsid protein VP2) from representative isolates of the 24 bluetongue virus serotypes.

P. Mertens, A. Samuel, S. Maan, 2004, Veterinaria italiana.

The use of African horse sickness virus VP7 antigen, synthesised in bacteria, and anti-VP7 monoclonal antibodies in a competitive ELISA.

A. Wade-Evans, C. Hamblin, R. O'Hara, 1993, Journal of virological methods.

VP7 from African horse sickness virus serotype 9 protects mice against a lethal, heterologous serotype challenge.

J. Burroughs, A. Wade-Evans, P. Mertens, 1998, Archives of virology. Supplementum.

The occurrence of encephalomyocarditis virus (EMCV) in European pigs from 1990 to 2001

M. Nielen, E. Brocchi, C. Billinis, 2005, Epidemiology and Infection.

Development of a mouse model system, coding assignments and identification of the genome segments controlling virulence of African horse sickness virus serotypes 3 and 8.

J. Burroughs, P. Mertens, L. A. Martín, 1998, Archives of virology. Supplementum.

Phylogenetic analysis of African horse sickness virus segment 10: sequence variation, virulence characteristics and cell exit.

P. Mellor, P. Mertens, L. A. Martín, 1998, Archives of virology. Supplementum.

Enhanced infectivity of modified bluetongue virus particles for two insect cell lines and for two Culicoides vector species.

P. Mellor, J. Burroughs, P. Mertens, 1996, Virology.

Genetic variability of encephalomyocarditis virus (EMCV) isolates.

H. Liebig, N. Knowles, C. Billinis, 2006, Veterinary microbiology.

African horsesickness virus VP7 sub-unit vaccine protects mice against a lethal, heterologous serotype challenge.

J. Burroughs, A. Wade-Evans, P. Mertens, 1997, The Journal of general virology.

Purification and properties of virus particles, infectious subviral particles, cores and VP7 crystals of African horsesickness virus serotype 9.

J. Burroughs, P. Mertens, C. Hamblin, 1994, The Journal of general virology.